{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T14:58:08Z","timestamp":1648997888111},"reference-count":20,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biopharmaceutical Statistics"],"published-print":{"date-parts":[[2019,11,2]]},"DOI":"10.1080\/10543406.2016.1239897","type":"journal-article","created":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T23:16:52Z","timestamp":1474931812000},"page":"1153-1169","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Methods for efficacy evaluations of antibacterial treatments in multiple body-site infection trials"],"prefix":"10.1080","volume":"29","author":[{"given":"Mohammad F.","family":"Huque","sequence":"first","affiliation":[{"name":"Office of Biostatistics, OTS, CDER, FDA, Silver Spring, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thamban","family":"Valappil","sequence":"additional","affiliation":[{"name":"Division of Biometrics IV, Office of Biostatistics, OTS, CDER, FDA, Silver Spring, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Alosh","sequence":"additional","affiliation":[{"name":"Division of Biometrics III, Office of Biostatistics, OTS, CDER, FDA, Silver Spring, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoxing","family":"Soon","sequence":"additional","affiliation":[{"name":"Division of Biometrics IV, Office of Biostatistics, OTS, CDER, FDA, Silver Spring, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,11,1]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2014.971169"},{"key":"CIT0002","unstructured":"Antibiotic Resistance Threats in the United States (2013). CDC report. URL http:\/\/www.cdc.gov\/drugresistance\/pdf\/ar-threats-2013-508.pdf (accessed 9\/2\/206)."},{"key":"CIT0003","unstructured":"Bretz, F., Hothorn, T., Wesfall, P. (2011). Multiple Comparisons Using R. CRC Press\/Taylor and Francis Group. URL http:\/\/crcpress.com."},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2003.08.009"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.2307\/3001616"},{"key":"CIT0006","unstructured":"CTTI Antibacterial Drug Development: Statistical Issues Think Tank Meeting. Clinical Trials Transformation Initiative website. http:\/\/www.ctti-clinicaltrials.org\/what-we-do\/investigational-plan\/abdd\/meetings\/think-tank (accessed 25\/4\/ 2016)."},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.2465"},{"key":"CIT0008","unstructured":"FDA draft guidance 2013: Antibacterial Therapies for Patients With Unmet Medical Need for the Treatment of Serious Bacterial Diseases. URL http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm359184.pdf (accessed 9\/2\/2016)."},{"key":"CIT0009","unstructured":"Gamalo-Siebers, M., Tiwari, R., LaVange, L. (2016). Flexible shrinkage estimation of subgroup effects through Drichlet process prior. Journal of Biopharmaceutical Statistics 2016 (Special Issue) URL http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10543406.2016.1226327."},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.4738"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6233"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis688"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2013.856021"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1177\/2168479013514418"},{"issue":"4","key":"CIT0015","first-page":"719","volume":"22","author":"Mantel N.","year":"1959","journal-title":"Journal of the National Cancer Institute"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/63.3.655"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.2307\/2528354"},{"key":"CIT0018","volume-title":"SAS 9.3 Help and Documentation","author":"Institute Inc SAS","year":"2002"},{"key":"CIT0019","unstructured":"The FDA Briefing information for the December 4, 2014 meeting of the Anti-Infective Drugs Advisory Committee: Clinical development issues for antibacterial drugs for patients with unmet medical need for the treatment of serious bacterial diseases. URL https:\/\/www.ctti-clinicaltrials.org\/briefing-room\/meetings\/ctti-antibacterial-drug-development-statistical-issues-think-tank-meeting (accessed on 10\/18\/2016)."},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1987.10478546"}],"container-title":["Journal of Biopharmaceutical Statistics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10543406.2016.1239897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T15:39:08Z","timestamp":1598715548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10543406.2016.1239897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,1]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11,2]]}},"alternative-id":["10.1080\/10543406.2016.1239897"],"URL":"https:\/\/doi.org\/10.1080\/10543406.2016.1239897","relation":{},"ISSN":["1054-3406","1520-5711"],"issn-type":[{"value":"1054-3406","type":"print"},{"value":"1520-5711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=lbps20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=lbps20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-11-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}